Journal Home
Search for

Volume 18, Issue 2, Pages 121-126 (February 2008)


View previous. 7 of 16 View next.

QT-interval dispersion in type 2 diabetic and non-diabetic patients with post-myocardial infarction

Koichi SakabeCorresponding Author Informationemail address, Nobuo Fukuda, Yamato Fukuda, Katsunori Wakayama, Teru Nada, Satofumi Morishita, Hisanori Shinohara, Yoshiyuki Tamura

Received 17 March 2006; received in revised form 1 September 2006; accepted 11 September 2006. published online 12 March 2007.

Abstract 

Background and aims

QT-interval dispersion (QTD), which reflects spatial ventricular repolarization inhomogeneity, has been reported to increase and to have a prognostic value in patients with either myocardial infarction or diabetes. Our aim was to compare increases in QTD in type 2 diabetic and non-diabetic patients following post-myocardial infarction (post-MI). We also compared QTD in type 2 diabetic patients with post-MI treated with insulin, sulfonylurea, or diet alone.

Methods and results

We determined the rate corrected QT-interval (QTc) dispersion (QTcD) in 178 consecutive post-MI patients, including 48 type 2 diabetic and 130 non-diabetic patients. The QTcD, measured with software (QTD-1), was defined as the difference in the minimum and maximum QTc in any of the 12 standard electrocardiographic leads. There were no significant differences in age, gender, left ventricular end-diastolic diameter, ejection fraction, or minimum QTc between type 2 diabetic and non-diabetic patients with post-MI. Compared with post-MI patients without diabetes, those with type 2 diabetes had higher maximum QTc (481±37 vs. 459±43ms, P<0.05) and QTcD (67±18 vs. 58±16ms, P<0.05). Among type 2 diabetic patients with post-MI treated with insulin, sulfonylurea, or diet alone, the QTcD (81±18 vs. 64±16 vs. 62±17ms, P<0.05, respectively) was significantly greater and the R-R interval was shorter in the insulin therapy group.

Conclusions

Type 2 diabetes is associated with an additional increase in the QTD in post-MI patients. This additional increase in spatial repolarization inhomogeneity might be implicated in the increased mortality risk in post-MI patients with type 2 diabetes. These findings were thought to be more striking in the insulin therapy group.

Department of Cardiology and Clinical Research, National Hospital Organization, Zentsuji National Hospital, 2-1-1, Senyu-cho, Zentsuji, Kagawa 765-0001, Japan

Corresponding Author InformationCorresponding author. Tel.: +81 877 622 211; fax: +81 877 631 601.

 Portions of the results were presented at the European Society of Cardiology Congress 2005, Stockholm, Sweden, September 3–7, 2005.

PII: S0939-4753(06)00199-2

doi:10.1016/j.numecd.2006.09.002


View previous. 7 of 16 View next.